Loading provider…
Loading provider…
Infectious Disease Physician in Foster City, CA
NPI: 1194928762HQ Phone
Get MD Mark's Phone Numberphone_androidMobile
Get MD Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1979 - 2027

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Infectious Disease
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Infectious Disease
1982 - 1983
UCLA-VA Greater Los Angeles
Internship • Internal Medicine
1978 - 1979
University of Illinois College of Medicine - Chicago
medicine.uic.edu
Medical School
Until 1978
Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease
Authors: Oliver A. Cornely, Johan Maertens, Mark Bresnik, Ramin Ebrahimi, Emma Dellow, Raoul Herbrecht, J. Peter Donnelly
Publication Date: 2011-09
Antifungal therapy patterns, healthcare utilization, costs, and mortality in central nervous system and non-central nervous system disseminated coccidioidomycosis acro...
Authors: Fariba Donovan, Mark Bresnik, Belinda Lovelace, Lia Pizzicato, Vamshi Ruthwik Anupindi
Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: A placebo-controlled trial
Authors: Noreen Henig, John Lipuma, George Retsch-Bogart
Journal: J Cyst Fibros
Publication Date: 2013-10-28
Lead Sponsor: Gilead Sciences
Collaborators: Galapagos NV
Intervention / Treatment: DRUG: Placebo to match MTX, DRUG: MTX, DRUG: Placebo to match filgotinib, DRUG: Filgotinib
Lead Sponsor: Gilead Sciences
Collaborators: Ono Pharmaceutical Co. Ltd
Intervention / Treatment: DRUG: Placebo, DRUG: Tirabrutinib
Lead Sponsor: Gilead Sciences
Intervention / Treatment: DRUG: GS-5737